Evidence map›Paper›PMID 40330016›Full record

ReviewFrontiers in cellular and infection microbiology2025

FAS mediates apoptosis, inflammation, and treatment of pathogen infection.

Liying Hu, Juane Lu, Hongfei Fan, Changcheng Niu, Yanping Han, Qinggele Caiyin, Hao Wu, Jianjun Qiao

Abstract readReview
In one paragraph

Review in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Single-Cell Profiling Reveals Clonally Expanded CX3CR1Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Triptolide clearsFrontiers in pharmacology · 2026
    Article
  15. Review
  16. The HIV-1 Vpr R77Q mutant alters host apoptotic gene regulation in CD4+ T cells.Frontiers in cellular and infection microbiology · 2026
    Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Liying Hu *School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Juane Lu *School of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Hongfei FanTianjin Key Laboratory of Food Science and Biotechnology, College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin, China.
Changcheng NiuSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Yanping HanSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Qinggele CaiyinSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.
Hao WuZhejiang Research Institute of Tianjin University (Shaoxing), Shaoxing, China.
Jianjun QiaoSchool of Chemical Engineering and Technology, Tianjin University, Tianjin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FAS cell surface death receptor, a member of the tumor necrosis factor receptor family, activates both apoptotic and non-apoptotic signaling upon interaction with its ligand FASL. It is critical in cell migration, invasion, immune responses, and carcinogenesis. Pathogen infection can influence host cells' behavior by modulating the FAS/FASL pathway, thereby influencing disease progression. Understanding the role of FAS signaling in the context of pathogen interactions is therefore crucial. This review examines FAS-mediated apoptotic and non-apoptotic signaling pathways, with particular emphasis on the mechanisms of apoptosis and inflammation induced by bacterial and viral infections. Additionally, it highlights therapeutic strategies, including drug, cytokine, antibody, and FASL recombinant protein therapies, providing new directions for treating pathogenic infections and cancers, as well as insights into developing novel therapeutic approaches.

Indexed as

ApoptosisBacterial Infectionsfas ReceptorHost-Pathogen InteractionsInflammationVirus DiseasesAnimalsFas Ligand ProteinHumansSignal TransductionFas Ligand Proteinfas ReceptorapoptosisbacteriaFASinflammationtreatmentvirus

Identifiers

PMID40330016
PMCPMC12052831

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.